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Abstract
Monilinia vaccinii-corymbosi (Reade) Honey (M.vc), the causal agent of Monilinia blight
of wild blueberry, is controlled primarily by fungicide applications. Demethylation-inhibiting
fungicides (DMIs) have been used for over 30 years for Monilinia blight control due to flexibility
of use (i.e., ability to use after an infection period) and disease control effectiveness and
consistency. In the present study, the sensitivity of ten M.vc isolates to three DMIs- propiconazole,
difenoconazole and prothioconazole-desthio were evaluated in vitro by a mycelial growth
inhibition assay. In addition, four field trials were conducted during two crop seasons: 2012 and
2013, to examine the efficacy of these DMIs to control Monilinia blight. All the tested DMIs were
effective in inhibiting mycelial growth of M.vc isolates, although the mean EC50 values differed
significantly. In field experiments, three of four trials had significant treatment effect on disease
incidence and severity of vegetative buds. Prothioconazole-desthio and propiconazole provided
consistent control against Monilinia blight. Conversely, difenoconazole was effective in in vitro
analysis, but did not demonstrate satisfactory Monilinia blight control in all field trials. In the 2012
trials, both prothioconazole-desthio and propiconazole reduced disease incidence of vegetative
buds by 100% compared to the untreated control. Prothioconazole-desthio reduced disease
development in 2013 with 94 and 99.8% less incidence, and 75 and 99.5% less severity. Similarly,
propiconazole also reduced incidence of vegetative buds by 88% and 99.8%, and severity by 54%
and 99.7%. No phytotoxic symptoms were observed in any of the field trials. The results of the
study serve as a benchmark to monitor shifts in M.vc sensitivity to these fungicides in the future.
Additional Keywords: Monilinia blight, lowbush blueberry, fungicide sensitivity,
propiconazole, prothioconazole-desthio, difenoconazole
Introduction
Monilinia blight, caused by Monilinia vaccinii-corymbosi (Reade) Honey (M.vc), is an
important yield-limiting, fungal disease of wild blueberries. The disease has two infection phases
with- the primary infection resulting in blighting of emerging vegetative and floral buds and the
secondary phase resulting in infection of flowers and developing berries producing pseudosclerotia
(mummy berries) (Hildebrand et al., 1995). Together, the primary and secondary infection
processes cause losses in leaf and floral tissue, yield potential and berry quality. Control measures
such as intense and uniform burning can be effective in destroying mummy berries (Delbridge and
Hildebrand, 1995), however, sequential burning has a high cost and reduces the organic matter
content in the soil. Annis and Yarborough (2014) stated that efficient harvest techniques reduces
the number of infected berries dropping to the ground. Although, these measures reduce the

1

number of infected berries left in the field, they may not give sufficient control of disease (Guo,
2016). Effective management of the disease relies heavily on the use of fungicide applications.
Demethylation inhibitors (DMIs) compose one of the most important group of fungicides
used for Monilinia blight control in Canada. DMIs specifically target the demethylation process at
C-14α demethylase and disrupt fungal sterol biosynthesis (Köller, 1988). The Monilinia vacciniicorymbosi populations in commercial wild blueberry fields in Nova Scotia have been exposed to
DMI fungicides for approximately 30 years since the first usage of triforine in the 1980s (Lockhart
et.al., 1983). It was replaced by propiconazole in the 1990s, and the wild blueberry producers have
been reliant on propiconazole for Monilinia blight control for past 20 years. Despite a history of
success in using propiconazole, inconsistent efficacy has been observed in research trials
conducted in Nova Scotia in 2007, 2008, 2010 (Percival and Beaton, 2012) and 2017. Extensive
and consecutive use of a specific fungicide can lead to a sensitivity shift toward resistant
populations of the pathogen to the fungicide (Brent and Hollomon, 2007). Furthermore, crossresistance can occur between fungicides that belong to the same chemical group or have the same
mode of action.
Consequently, studies completed by Percival and Beaton (2012) reported prothioconazoledesthio as an effective Monilinia blight control product, with the additional benefit of no residues
detected in harvested or processed berries. The importance of assessing other DMIs for Monilinia
blight became more apparent with propiconazole being declared a human health risk by the
European Union (WTO, 2018). Since propiconazole has been extensively used for Monilinia blight
control and site- specific fungicides are prone to resistance development, assessing the sensitivity
of M.vc to the most commonly used DMI is crucial for Monilinia blight management. This study
was conducted to determine the sensitivity of M.vc isolates to DMI group fungicides
(propiconazole, prothioconazole-desthio and difenoconazole) and to investigate the ability of these
fungicides to control Monilinia blight in commercial wild blueberry fields.
Materials and Methods
Monilinia vaccinii-corymbosi isolates
Isolates were collected from mummy berries and Monilinia blighted shoots from five
commercial wild blueberry fields in Nova Scotia during 2011 to 2013. Mummy berries and
Monilinia blighted shoots were surface sterilized and blocks of white medulla cut from the center
of mummy berries and pieces of blighted leaves were inoculated onto potato dextrose agar (PDA)
plates amended with antibiotics (0.5mg mL-1 streptomycin sulfate, 0.5mg mL-1 penicillin) to
suppress bacterial growth. Petri dishes were incubated at 22 ± 2 °C for further mycelial growth.
Determination of fungicide sensitivity
The fungicides used in this study were the pure technical grade active ingredients:
propiconazole (Syngenta Honeywood Research Farm, Platisville, ON, CA), prothioconazoledesthio (Bayer Crop Science, MO, US) and difenoconazole (Syngenta Honeywood Research
Farm, Platisville, ON, CA). Stock solutions/suspensions of fungicides were prepared by dissolving
active ingredients in acetone on the day of the experiment. Autoclaved PDA was amended with 0,
0.005, 0.01, 0.05, 0.1 μg mL-1 propiconazole and difenoconazole and 0, 0.001, 0.002, 0.003, 0.004
μg mL-1 prothioconazole-desthio. The control medium was not amended with fungicides. In all
cases, including the control plates, the final acetone concentration was 0.1 % (v/v). Tests for each
isolate were replicated three times per concentration of each fungicide.
2

Sensitivity of 10 isolates was estimated based on mycelium growth inhibition assay
(Golembiewski et al., 1995; Hu et al., 2011; Wise et al., 2011). For each isolate, a 4mm- diameter
mycelial plug was cut from the edge of a 10-day-old colony grown on PDA medium and placed
upside down on fungicide- amended and un-amended media. The plates were incubated at 22 ± 2
°C in the dark. After 7 days, the colony diameter was measured in two perpendicular directions,
and the diameter of the mycelial plug was subtracted before calculating the mean diameter of the
colony. For each concentration/fungicide, the EC50 value (effective concentration that reduced
mycelial growth by 50%) was calculated by regressing the relative growth (RG: colony diameter
on fungicide-amended medium divided by colony diameter on unamended medium × 100) against
the log10 fungicide concentration. As per the reports of Thompson and Annis (2014), mean EC50
value for baseline isolates from unmanaged fields of Maine to propiconazole is 0.016 g μg mL-1.
Since there were no previous references of M.vc to difenoconazole and prothioconazole-desthio,
EC50 values lower than the EC50 found for propiconazole (0.016 μg mL-1, (Thompson and Annis,
2014) were considered “sensitive” (S); EC50 values ranging from 0.016 to 1.0 µg mL-1 were
considered “moderately sensitive” (MS); and EC50 values above 1.0 µg mL-1 were considered
“non-sensitive” (NS). The variation factor (VF) to fungicides was calculated as the highest EC50
value divided by the lowest EC50 value, in order to evaluate the extent of variability in fungicide
sensitivity among the populations.
Field Experiments
Field trials were conducted during 2012 and 2013 to determine the efficacy of the three
DMIs against natural infections caused by M.vc. Experiments were performed in the cropping
phase of production in four commercial wild blueberry fields. Two trials were located at
Kemptown, Nova Scotia (NS) (coordinates = 45° 30´ N, 63° 07´ W) and Aulac, New Brunswick
(NB) (coordinates = 45° 53´ N, 64° 16´ W) in 2012. The other two field trials were located at Mt.
Thom, NS (coordinates = 45° 29´ N, 62° 59´ W) and Farmington, NS (coordinates = 45° 34´ N,
63° 53´ W) in 2013. The trials were in a randomized complete block design with five replications.
Each plot was 4 × 6 m with 2m buffers between plots.
DMI treatments consisted of application of Proline® 480SC (a.i. prothioconazole) at 300
mL product·ha-1, Tilt® 250E (a.i. propiconazole) at 500 mL product·ha-1, and Inspire® (a.i.
difenoconazole) at 80 g product·ha-1. A 2000 series Watchdog® weather station (Spectrum
Technologies, Inc. Plainfield, IL, US) was set up in the center of each trial to monitor air
temperature, relative humidity, wind speed and direction, and leaf wetness every minute.
Fungicides were sprayed two times. The first application was done when the field reached to 40 –
50 % V2 and/or F2 stage (V2: 2 - 5 mm green leaf tissue emerged, F2: floral bud scales separating).
The second application was done 7 to 9 days after the first application. The timing was decided by
consulting with the Monilinia forecasting system (which uses temperature, wetness duration, spore
dispersal, and developing stage of vegetative and/or floral buds), which was available at lowbush
blueberry blog (provided by Perennia, Truro, NS, CA). In 2012, fungicide applications were made
on May 2 and May 11 at the Kemptown site and on April 30 and May 8 at the Aulac site. In 2013,
fungicide applications performed on May 8 and May 17 at the Mt. Thom site and on May 7 and
May 14 at the Farmington site. Each fungicide was mixed with distilled water and was applied
using a Bell spray Inc. ® hand held sprayer with a 2-m CO2 propelled boom and 4 TeeJet Visiflow
8003VS nozzles. The sprayer pressure was 32 PSI (220 kPa). The nozzle discharge rate was 12.5
mL·s-1 and application ground speed was approximately 1.19 m·s-1.
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Disease assessment
Disease incidence and severity were visually assessed on fifteen randomly selected stems
per plot using a line transect (samples were collected every 4.5 m along the transect). Since
symptoms of Monilinia blight do not show until 10 to 17 days after the susceptible buds were
infected by the ascospores (Delbridge and Hildebrand, 1995), first assessments occurred prior to
the second fungicide applications, which were 7 to 9 days after first fungicide application. Second
assessment occurred within 2 weeks after the second fungicide applications.
Disease incidence was determined by percentage of floral buds and/or vegetative buds per stem
with visual symptoms of Monilinia blight. While, severity was determined by percentage of
infected area per flower or leaf with visual symptoms of Monilinia blight within a stem. The
suppression efficacy of fungicides was determined by comparing the disease incidence and
severity of wild blueberry plants sprayed with fungicides to the control trials (without fungicide).
Phytotoxicity was assessed visually by examining the floral/vegetative buds of each stem for
phytotoxic symptoms. The impact of the treatments on yield potential was determined by
examining parameters including stem length, number of vegetative nodes, floral nodes, set fruit
(adequately pollinated and fertilized marketable blueberries) and, pinheads (small under-formed
and unmarketable blueberries).
In August, berries were harvested from the field. A forty-tine, commercial wild blueberry hand
rake was used to harvest berries from four randomly selected 1-m2 quadrats in each plot. Harvested
berry yield was recorded using a bench scale.
Data Analysis
For in vitro tests, analysis of variance was completed using the PROC Mixed procedure of
SAS (version 9.3, SAS institute, Inc., Cary, NC), using a factorial design of isolates and active
ingredients, with the replicate as the blocking factor. Orthogonal contrasts and Tukey’s mean
comparison test were used. The PROC CORR procedure of SAS was used for correlation analysis.
For in vivo tests, analysis of variance for all the data collected from the experiment was completed
using the PROC MIXED procedures of SAS (version 9.3, SAS institute, Inc., Cary, NC). LSD was
used for multiple means comparison at the level of α = 0.05.
Results and Discussion
Sensitivity of Monilinia vaccinii-corymbosi to DMI fungicides
DMI fungicides are the dominant fungicide products for Monilinia blight control in wild
blueberry production in Nova Scotia due to: their disease control efficiency, ease of use, low cost,
and economic benefits. However, there is concern that the M.vc populations in commercial wild
blueberry fields in Nova Scotia may have developed reduced sensitivity to propiconazole because
of their extensive and consecutive usage for past 20 years. In the present study, none of the tested
isolates exhibited reduced sensitivity, although, the mean EC50 value differed significantly among
each of the tested fungicides (Table 1). Prothioconazole-desthio was the most effective inhibitor
with a mean EC50 of 0.00086 μg·mL-1. Difenoconazole was found to be more effective in inhibiting
mycelial growth on PDA medium than propiconazole.
Although, propiconazole maintained its overall effectiveness against M.vc isolates,
inconsistency existed among the isolates. This might be due to a relatively wider range observed
in propiconazole EC50 value than prothioconazole-desthio and difenoconazole (Table 1). This
inconsistency could be attributed to its erratic efficacy, as observed in the field research trials.
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Thompson and Annis (2014) found that isolates of M. vaccinii-corymbosi from unmanaged areas
has EC50 value of 0.016 μg·mL-1 for propiconazole. In our analysis, the mean propiconazole EC50
value was 0.012 μg·mL-1, which was lower than the baseline value, which indicates the isolates
are sensitive to propiconazole. Similarly, the isolates were not exposed to prothioconazole-desthio
and difenoconazole before the year 2014; consequently, data were not available for comparisons.
Thus, EC50 results of prothioconazole-desthio and difenoconazole provided valuable information
concerning the normal variation in fungicide sensitivity of M.vc, which can be used as a baseline
for further sensitivity analysis.
Table 1. Inhibitory effect of each active ingredient on mycelial growth of ten M. vacciniicorymbosi isolates from commercial wild blueberry fields in Nova Scotia and their
comparison using Tukey’s LSD
EC50 values (μg·mL-1)a
Active ingredient
Range
Meanb
Variation factorc
Propiconazole
0.008-0.016
0.012 a
2
Difenoconazole
0.006-0.0083
0.0068 b
1.4
Prothioconazole-desthio 0.00076-0.0012
0.00086 c
1.6
a
EC50 value is the effective concentration that inhibit mycelial growth by 50%
b
Means that share the same letter is not significant different from each other. Proc Mixed
procedure was used for analysis of variance (ANOVA)
c
Variation factor = highest EC50 value divided by lowest EC50 value
It is well documented that different DMIs can show distinct but consistent cross-resistance
patterns (Hildebrand et al., 1988; Köller & Wubben, 1989; Kendall et al., 1993). Cross-resistance
is generally accepted to be present among DMI fungicides active against the same fungus
(Fungicide Resistance Action Committee, 2015) because of their unique mode of action. A study
by Holb and Schnabel (2007) observed cross-resistance among triazoles by noting their effects on
M. fructicola on peach. In this study, propiconazole EC50 values were significantly correlated with
difenoconazole EC50 values and prothioconazole-desthio EC50 values at the level of α=0.05 (Table2). A high correlation between propiconazole and prothioconazole-desthio was found (r = 0.73).
However, the correlation between propiconazole and difenoconazole was very weak (r = 0.39)
Correlation implies the possible emergence of cross-resistance among these DMIs. Development
of reduced sensitivity or resistance of M. vaccinii-corymbosi to propiconazole would have an
impact on control efficacy of prothioconazole and difenoconazole. A moderate cross-resistance
between propiconazole and difenoconazole has been reported for Alternaria alternata isolates on
pistachio (Avenot et al., 2016). As per Thomas et al. (2012), cross-resistance among DMI
fungicides is not universal. Several studies also documented the lack of cross-resistance among
DMIs (Leroux et al., 2000; Thomas et al., 2012). Thus, we cannot assume the existence of a
positive cross-resistance between fungicides with a similar mode of action. Moreover, the sample
size used in this study was relatively small. A larger sample size may have provided better
correlation results.
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Table 2. Pearson correlation coefficient (r) values of EC50 values for propiconazole,
difenoconazole and prothioconazole-desthio
Difienoconazole
Prothioconazole-desthio
Active
ingredient
Pr
P-value
r
value
Propiconazole
0.39
0.038
0.73
<0.001
Difenoconazole 0.17
0.4
Effect of DMI fungicides on Monilinia blight control on field conditions
Monilinia blight incidence was observed to be higher on leaf tissues than floral tissues in
all trials in 2012 and 2013. There was a significant interaction among fungicide treatment and field
trials. This significance led us to carry out one-way ANOVA for each of the field trials. In the
field trials of this study, vegetative and floral buds did not show any Monilinia blight symptoms
after the first fungicide application. Relatively dry weather at the field trials in 2012 and 2013
might have contributed to low disease pressure, which was in contrast to severe Monilinia blight
pressure in 2009 (D. Percival, personal communication, Dalhousie University, NS, CA).
Similarly, in the four field experiments, only three fields demonstrated significant
treatment effects (Table-3). In the trials conducted in 2012, the Aulac trial did not demonstrate
significant treatment effects. However, the disease incidence and severity of vegetative buds in the
Kemptown trial ranged from 0 % to 0.3 % and 0 % to 1.01 % respectively. Even though, the
fungicides did not show a suppressive effect on disease incidence, they significantly lowered
disease severity by 100 %.
In 2013, trials conducted in Farmington and Mt. Thom, the Monilinia blight disease
pressure was found to be higher than 2012. After the second fungicide application, in the
Farmington trial, prothioconazole-desthio, propiconazole and difenoconazole lowered disease
incidence of vegetative buds by 94 %, 88% and 27 % and disease severity by 75 %, 52 % and 10
% respectively. In the Mt. Thom trial, compared to untreated control, prothioconazole-desthio and
propiconazole significantly decreased disease incidence and disease severity of vegetative buds by
100 %. However, difenoconazole lowered disease incidence and severity by 89 % and 86 %
respectively. No significant treatment effect was observed on the physical development of wild
blueberry plants or berry yield after the first and second fungicide applications in all trials. This
might be due to the low disease incidence on floral buds as observed in all field trials (data not
shown).
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Table 3. Influence of DMI fungicides on the suppression of Monilinia blight on vegetative
buds on trials with significant treatment effects after second fungicide application
Treatment
2012/Kemptown
2013/Farmington
2013/Mt.Thom
a
b
a
b
DI (%)
DS (%)
DI (%)
DS (%)
DIa (%)
DSb (%)
Untreated
0.3
1.01
4.18
15.4
1.22
6.18
Proline® 480SC
0
0
0.24
3.87
0.003
0.03
Tilt® 250E
0
0
0.51
7.33
0.003
0.02
Inspire®
0.07
0.23
3.07
13.8
0.14
0.89
ANOVA resultsc
NS
P=0.04
P=0.02
P=0.048
P=0.01
P=0.02
a
DI (Disease incidence) = 0 to 100% where 0 = no vegetative buds affected and 100 = all vegetative
buds are affected with at least one lesion.
b
DS (Disease severity) = 0 to 100% where 0 = no disease and 100 = one whole vegetative bud is
affected
c
Analysis of variance (ANOVA) results refer to treatment effects that were either not significant
(NS) or significant at p<0.05. Mean separation was completed using LSD multiple means
comparison test procedure (ά=0.05).
DMIs represent one of the largest groups of systemic fungicides that have been used to
control agriculturally important fungal pathogens (Zhan et al., 2006). In the present study,
prothioconazole-desthio and propiconazole provided consistent control against Monilinia blight.
Among these, prothioconazole-desthio was the most effective fungicide product that showed
significant reduction in disease incidence and severity of vegetative buds for all trials (Table-3).
These are similar to the results observed in field research trials conducted in 2009 (Percival and
Beaton, 2012). However, it should be noted that difenoconazole did not suppress Monilinia blight
in the field trials, but was effective in in vitro inhibition of mycelial growth. Despite long-term
use, M.vc populations are still sensitive to propiconazole.
Conclusion
According to the results from the in vitro sensitivity study of M.vc isolates and in vivo
fungicide efficacy examination for Monilinia blight control, the M. vaccinii-corymbosi populations
affecting lowbush blueberry had not developed reduced sensitivity or resistance to the DMIs used
in this study and this class of fungicides remains the most effective. Besides difenoconazole, the
in vivo results were consistent with in vitro results that prothioconazole-desthio and propiconazole
had higher control efficacy against Monilinia blight in field trials. The information presented in
the study can be used to evaluate population shifts in fungicide sensitivity in subsequent years.
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